2023-2029 Global Temporal Arteritis Industry Research & Trends Analysis Report
2023-2029 Global Temporal Arteritis Industry Research & Trends Analysis Report
The Temporal Arteritis Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Research, the global market for Temporal Arteritis should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Temporal Arteritis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Temporal Arteritis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Temporal Arteritis include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd and Pfizer Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.
This report aims to provide a comprehensive study of the global market for Temporal Arteritis. Report Highlights:
(1) Global Temporal Arteritis market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Temporal Arteritis market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Temporal Arteritis market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Temporal Arteritis segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Temporal Arteritis segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Temporal Arteritis, capacity, production and trends.
(7) Temporal Arteritis industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral
Parenteral
Market segment by application, can be divided into
Hospital
Home Care
Other
Market segment by players, this report covers
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann -La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Amorphex Therapeutics Holdings, Inc
Bausch Health Companies Inc
Regeneron Pharmaceuticals Inc
Astellas Pharma Inc
1 Market Overview
1.1 Temporal Arteritis Definition
1.2 Global Temporal Arteritis Market Size and Forecast
1.2.1 By Revenue, Global Temporal Arteritis Market Size, 2018-2029
1.2.2 By Sales Volume, Global Temporal Arteritis Market Size, 2018-2029
1.2.3 Global Temporal Arteritis Price Trend, 2018-2029
1.3 China Temporal Arteritis Market Size and Forecast
1.3.1 By Revenue, China Temporal Arteritis Market Size, 2018-2029
1.3.2 By Sales Volume, China Temporal Arteritis Market Size, 2018-2029
1.3.3 China Temporal Arteritis Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Temporal Arteritis Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Temporal Arteritis Share in Global Market, 2018-2029
1.4.3 Temporal Arteritis Market Size: China VS Global, 2018-2029
1.5 Temporal Arteritis Market Dynamics
1.5.1 Temporal Arteritis Market Drivers
1.5.2 Temporal Arteritis Market Restraints
1.5.3 Temporal Arteritis Industry Trends
1.5.4 Temporal Arteritis Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Temporal Arteritis Revenue by Company, 2018-2023
2.2 Global Temporal Arteritis Sales Volume by Company, 2018-2023
2.3 Global Temporal Arteritis Price by Company, 2018-2023
2.4 Global Temporal Arteritis Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Temporal Arteritis Concentration Ratio
2.6 Global Temporal Arteritis Mergers & Acquisitions, Expansion Plans
2.7 Global Temporal Arteritis Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Temporal Arteritis Revenue by Company, 2018-2023
3.2 China Temporal Arteritis Sales Volume by Company, 2018-2023
3.3 China Temporal Arteritis Temporal Arteritis Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Temporal Arteritis Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Temporal Arteritis Domestic VS Export
3.6 China Market, Temporal Arteritis Import & Export
3.6.1 China Market, Temporal Arteritis Import & Export, 2018-2029
3.6.2 China Temporal Arteritis Import & Export Trends
3.6.3 Main Sources of China Temporal Arteritis Import
3.6.4 Export Destination of China Temporal Arteritis
4 Temporal Arteritis Production by Region
4.1 Global Temporal Arteritis Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Temporal Arteritis Manufacturers
4.3 Global Major Manufacturers, Temporal Arteritis Capacity Expansion and Future Plans
4.4 Global Temporal Arteritis Capacity by Region
4.5 Global Temporal Arteritis Production by Region
4.5.1 Global Temporal Arteritis Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Temporal Arteritis Production by Region, 2018-2023
4.5.3 Global Temporal Arteritis Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Temporal Arteritis Industry Chain
5.2 Temporal Arteritis Upstream Analysis
5.2.1 Temporal Arteritis Core Raw Materials
5.2.2 Main Manufacturers of Temporal Arteritis Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Temporal Arteritis Production Mode
5.6 Temporal Arteritis Procurement Model
5.7 Temporal Arteritis Industry Sales Model and Sales Channels
5.7.1 Temporal Arteritis Sales Model
5.7.2 Temporal Arteritis Typical Distributors
6 Sights by Type
6.1 Temporal Arteritis Classification
6.1.1 Oral
6.1.2 Parenteral
6.2 By Type, Global Temporal Arteritis Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Temporal Arteritis Revenue, 2018-2029
6.4 By Type, Global Temporal Arteritis Sales Volume, 2018-2029
6.5 By Type, Global Temporal Arteritis Price, 2018-2029
7 Sights by Application
7.1 Temporal Arteritis Segment by Application
7.1.1 Hospital
7.1.2 Home Care
7.1.3 Other
7.2 By Application, Global Temporal Arteritis Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Temporal Arteritis Revenue, 2018-2029
7.4 By Application, Global Temporal Arteritis Sales Volume, 2018-2029
7.5 By Application, Global Temporal Arteritis Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Temporal Arteritis Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Temporal Arteritis Revenue, 2018-2029
8.3 By Region, Global Temporal Arteritis Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Temporal Arteritis Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Temporal Arteritis Market Size Market Share
8.5 Europe
8.5.1 Europe Temporal Arteritis Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Temporal Arteritis Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Temporal Arteritis Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Temporal Arteritis Market Size Market Share
8.7 South America
8.7.1 South America Temporal Arteritis Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Temporal Arteritis Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Temporal Arteritis Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Temporal Arteritis Revenue, 2018-2029
9.3 By Country, Global Temporal Arteritis Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Temporal Arteritis Market Size, 2018-2029
9.4.2 By Company, U.S. Temporal Arteritis Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Temporal Arteritis Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Temporal Arteritis Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Temporal Arteritis Market Size, 2018-2029
9.5.2 By Company, Europe Temporal Arteritis Sales Volume Market Share, 2022
9.5.3 By Type, Europe Temporal Arteritis Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Temporal Arteritis Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Temporal Arteritis Market Size, 2018-2029
9.6.2 By Company, China Temporal Arteritis Sales Volume Market Share, 2022
9.6.3 By Type, China Temporal Arteritis Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Temporal Arteritis Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Temporal Arteritis Market Size, 2018-2029
9.7.2 By Company, Japan Temporal Arteritis Sales Volume Market Share, 2022
9.7.3 By Type, Japan Temporal Arteritis Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Temporal Arteritis Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Temporal Arteritis Market Size, 2018-2029
9.8.2 By Company, South Korea Temporal Arteritis Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Temporal Arteritis Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Temporal Arteritis Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Temporal Arteritis Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Temporal Arteritis Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Temporal Arteritis Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Temporal Arteritis Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Temporal Arteritis Market Size, 2018-2029
9.10.2 By Company, India Temporal Arteritis Sales Volume Market Share, 2022
9.10.3 By Type, India Temporal Arteritis Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Temporal Arteritis Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Temporal Arteritis Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Temporal Arteritis Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Temporal Arteritis Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Temporal Arteritis Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis AG
10.1.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.1.2 Novartis AG Temporal Arteritis Models, Specifications and Application
10.1.3 Novartis AG Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis AG Company Profile and Main Business
10.1.5 Novartis AG Recent Developments
10.2 Endo International Inc
10.2.1 Endo International Inc Company Information, Head Office, Market Area and Industry Position
10.2.2 Endo International Inc Temporal Arteritis Models, Specifications and Application
10.2.3 Endo International Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Endo International Inc Company Profile and Main Business
10.2.5 Endo International Inc Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 Teva Pharmaceutical Industries Ltd Temporal Arteritis Models, Specifications and Application
10.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Glenmark Pharmaceuticals Ltd
10.4.1 Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Glenmark Pharmaceuticals Ltd Temporal Arteritis Models, Specifications and Application
10.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Glenmark Pharmaceuticals Ltd Company Profile and Main Business
10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments
10.5 Cipla Inc
10.5.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.5.2 Cipla Inc Temporal Arteritis Models, Specifications and Application
10.5.3 Cipla Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cipla Inc Company Profile and Main Business
10.5.5 Cipla Inc Recent Developments
10.6 Dr Reddy's Laboratories Ltd
10.6.1 Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
10.6.2 Dr Reddy's Laboratories Ltd Temporal Arteritis Models, Specifications and Application
10.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Dr Reddy's Laboratories Ltd Company Profile and Main Business
10.6.5 Dr Reddy's Laboratories Ltd Recent Developments
10.7 Abbott
10.7.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.7.2 Abbott Temporal Arteritis Models, Specifications and Application
10.7.3 Abbott Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abbott Company Profile and Main Business
10.7.5 Abbott Recent Developments
10.8 F. Hoffmann -La Roche Ltd
10.8.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.8.2 F. Hoffmann -La Roche Ltd Temporal Arteritis Models, Specifications and Application
10.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business
10.8.5 F. Hoffmann -La Roche Ltd Recent Developments
10.9 Pfizer Inc
10.9.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.9.2 Pfizer Inc Temporal Arteritis Models, Specifications and Application
10.9.3 Pfizer Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Pfizer Inc Company Profile and Main Business
10.9.5 Pfizer Inc Recent Developments
10.10 Zydus Group
10.10.1 Zydus Group Company Information, Head Office, Market Area and Industry Position
10.10.2 Zydus Group Temporal Arteritis Models, Specifications and Application
10.10.3 Zydus Group Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zydus Group Company Profile and Main Business
10.10.5 Zydus Group Recent Developments
10.11 Lupin
10.11.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.11.2 Lupin Temporal Arteritis Models, Specifications and Application
10.11.3 Lupin Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Lupin Company Profile and Main Business
10.11.5 Lupin Recent Developments
10.12 Amorphex Therapeutics Holdings, Inc
10.12.1 Amorphex Therapeutics Holdings, Inc Company Information, Head Office, Market Area and Industry Position
10.12.2 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Models, Specifications and Application
10.12.3 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Amorphex Therapeutics Holdings, Inc Company Profile and Main Business
10.12.5 Amorphex Therapeutics Holdings, Inc Recent Developments
10.13 Bausch Health Companies Inc
10.13.1 Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
10.13.2 Bausch Health Companies Inc Temporal Arteritis Models, Specifications and Application
10.13.3 Bausch Health Companies Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Bausch Health Companies Inc Company Profile and Main Business
10.13.5 Bausch Health Companies Inc Recent Developments
10.14 Regeneron Pharmaceuticals Inc
10.14.1 Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position
10.14.2 Regeneron Pharmaceuticals Inc Temporal Arteritis Models, Specifications and Application
10.14.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Regeneron Pharmaceuticals Inc Company Profile and Main Business
10.14.5 Regeneron Pharmaceuticals Inc Recent Developments
10.15 Astellas Pharma Inc
10.15.1 Astellas Pharma Inc Company Information, Head Office, Market Area and Industry Position
10.15.2 Astellas Pharma Inc Temporal Arteritis Models, Specifications and Application
10.15.3 Astellas Pharma Inc Temporal Arteritis Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Astellas Pharma Inc Company Profile and Main Business
10.15.5 Astellas Pharma Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Temporal Arteritis Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Temporal Arteritis Market Restraints
Table 3. Temporal Arteritis Market Trends
Table 4. Temporal Arteritis Industry Policy
Table 5. Global Temporal Arteritis Revenue by Company, 2018-2023, US$ million
Table 6. Global Temporal Arteritis Revenue Market Share by Company, 2018-2023
Table 7. Global Temporal Arteritis Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Temporal Arteritis Sales Volume Market Share by Company, 2018-2023
Table 9. Global Temporal Arteritis Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Temporal Arteritis Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Temporal Arteritis Mergers & Acquisitions, Expansion Plans
Table 12. Global Temporal Arteritis Manufacturers Product Type
Table 13. China Temporal Arteritis Revenue by Company, 2018-2023, US$ million
Table 14. China Temporal Arteritis Revenue Market Share by Company, 2018-2023
Table 15. China Temporal Arteritis Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Temporal Arteritis Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Temporal Arteritis Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Temporal Arteritis Import & Export Trends
Table 19. Main Sources of China Temporal Arteritis Import
Table 20. Export Destination of China Temporal Arteritis
Table 21. Global Headquarters and Manufacturing Base of Temporal Arteritis Manufacturers
Table 22. Global Major Manufacturers, Temporal Arteritis Capacity Expansion and Future Plans
Table 23. Global Temporal Arteritis Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Temporal Arteritis Production by Region, 2018-2023, (K Units)
Table 25. Global Temporal Arteritis Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Temporal Arteritis Upstream (Raw Materials)
Table 27. Global Temporal Arteritis Typical Customers
Table 28. Temporal Arteritis Typical Distributors
Table 29. By Type, Global Temporal Arteritis Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Temporal Arteritis Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Temporal Arteritis Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Temporal Arteritis Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Temporal Arteritis Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Temporal Arteritis Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Temporal Arteritis Revenue Market Share, 2018-2029
Table 37. By Country, Global Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Temporal Arteritis Sales Volume Market Share, 2018-2029
Table 39. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 40. Novartis AG Temporal Arteritis Models, Specifications and Application
Table 41. Novartis AG Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis AG Company Profile and Main Business
Table 43. Novartis AG Recent Developments
Table 44. Endo International Inc Company Information, Head Office, Market Area and Industry Position
Table 45. Endo International Inc Temporal Arteritis Models, Specifications and Application
Table 46. Endo International Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Endo International Inc Company Profile and Main Business
Table 48. Endo International Inc Recent Developments
Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 50. Teva Pharmaceutical Industries Ltd Temporal Arteritis Models, Specifications and Application
Table 51. Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 53. Teva Pharmaceutical Industries Ltd Recent Developments
Table 54. Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Glenmark Pharmaceuticals Ltd Temporal Arteritis Models, Specifications and Application
Table 56. Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Glenmark Pharmaceuticals Ltd Company Profile and Main Business
Table 58. Glenmark Pharmaceuticals Ltd Recent Developments
Table 59. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 60. Cipla Inc Temporal Arteritis Models, Specifications and Application
Table 61. Cipla Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Cipla Inc Company Profile and Main Business
Table 63. Cipla Inc Recent Developments
Table 64. Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
Table 65. Dr Reddy's Laboratories Ltd Temporal Arteritis Models, Specifications and Application
Table 66. Dr Reddy's Laboratories Ltd Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Dr Reddy's Laboratories Ltd Company Profile and Main Business
Table 68. Dr Reddy's Laboratories Ltd Recent Developments
Table 69. Abbott Company Information, Head Office, Market Area and Industry Position
Table 70. Abbott Temporal Arteritis Models, Specifications and Application
Table 71. Abbott Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Abbott Company Profile and Main Business
Table 73. Abbott Recent Developments
Table 74. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 75. F. Hoffmann -La Roche Ltd Temporal Arteritis Models, Specifications and Application
Table 76. F. Hoffmann -La Roche Ltd Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. F. Hoffmann -La Roche Ltd Company Profile and Main Business
Table 78. F. Hoffmann -La Roche Ltd Recent Developments
Table 79. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 80. Pfizer Inc Temporal Arteritis Models, Specifications and Application
Table 81. Pfizer Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Pfizer Inc Company Profile and Main Business
Table 83. Pfizer Inc Recent Developments
Table 84. Zydus Group Company Information, Head Office, Market Area and Industry Position
Table 85. Zydus Group Temporal Arteritis Models, Specifications and Application
Table 86. Zydus Group Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Zydus Group Company Profile and Main Business
Table 88. Zydus Group Recent Developments
Table 89. Lupin Company Information, Head Office, Market Area and Industry Position
Table 90. Lupin Temporal Arteritis Models, Specifications and Application
Table 91. Lupin Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Lupin Company Profile and Main Business
Table 93. Lupin Recent Developments
Table 94. Amorphex Therapeutics Holdings, Inc Company Information, Head Office, Market Area and Industry Position
Table 95. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Models, Specifications and Application
Table 96. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Amorphex Therapeutics Holdings, Inc Company Profile and Main Business
Table 98. Amorphex Therapeutics Holdings, Inc Recent Developments
Table 99. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
Table 100. Bausch Health Companies Inc Temporal Arteritis Models, Specifications and Application
Table 101. Bausch Health Companies Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bausch Health Companies Inc Company Profile and Main Business
Table 103. Bausch Health Companies Inc Recent Developments
Table 104. Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position
Table 105. Regeneron Pharmaceuticals Inc Temporal Arteritis Models, Specifications and Application
Table 106. Regeneron Pharmaceuticals Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Regeneron Pharmaceuticals Inc Company Profile and Main Business
Table 108. Regeneron Pharmaceuticals Inc Recent Developments
Table 109. Astellas Pharma Inc Company Information, Head Office, Market Area and Industry Position
Table 110. Astellas Pharma Inc Temporal Arteritis Models, Specifications and Application
Table 111. Astellas Pharma Inc Temporal Arteritis Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Astellas Pharma Inc Company Profile and Main Business
Table 113. Astellas Pharma Inc Recent Developments
List of Figure
Figure 1. Temporal Arteritis Picture
Figure 2. By Revenue, Global Temporal Arteritis Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Temporal Arteritis Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Temporal Arteritis Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Temporal Arteritis Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Temporal Arteritis Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Temporal Arteritis Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Temporal Arteritis Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Temporal Arteritis Share of Global Market, 2018-2029
Figure 10. Global Temporal Arteritis Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Temporal Arteritis Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Temporal Arteritis Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Temporal Arteritis Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Temporal Arteritis Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Temporal Arteritis Domestic VS Export, 2022
Figure 16. Global Temporal Arteritis Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Temporal Arteritis Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Temporal Arteritis Production Market Share & Forecast by Region, 2018-2029
Figure 19. Temporal Arteritis Industry Chain
Figure 20. Temporal Arteritis Procurement Model
Figure 21. Temporal Arteritis Sales Model
Figure 22. Temporal Arteritis Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. Parenteral
Figure 25. By Type, Global Temporal Arteritis Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Temporal Arteritis Revenue Market Share, 2018-2029
Figure 27. By Type, Global Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Temporal Arteritis Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Temporal Arteritis Price, 2018-2029, (US$/Unit)
Figure 30. Hospital
Figure 31. Home Care
Figure 32. Other
Figure 33. By Application, Global Temporal Arteritis Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Temporal Arteritis Revenue Market Share, 2018-2029
Figure 35. By Application, Global Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Temporal Arteritis Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Temporal Arteritis Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Temporal Arteritis Revenue Market Share, 2018-2029
Figure 39. By Region, Global Temporal Arteritis Sales Volume Market Share, 2018-2029
Figure 40. North America Temporal Arteritis Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Temporal Arteritis Revenue Market Share, 2022
Figure 42. Europe Temporal Arteritis Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Temporal Arteritis Revenue Market Share, 2022
Figure 44. Asia Pacific Temporal Arteritis Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Temporal Arteritis Revenue Market Share, 2022
Figure 46. South America Temporal Arteritis Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Temporal Arteritis Revenue Market Share, 2022
Figure 48. Middle East & Africa Temporal Arteritis Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. Temporal Arteritis Market Share, 2022
Figure 51. By Type, U.S. Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe Temporal Arteritis Market Share, 2022
Figure 55. By Type, Europe Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 57. China Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China Temporal Arteritis Market Share, 2022
Figure 59. By Type, China Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan Temporal Arteritis Market Share, 2022
Figure 63. By Type, Japan Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea Temporal Arteritis Market Share, 2022
Figure 67. By Type, South Korea Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia Temporal Arteritis Market Share, 2022
Figure 71. By Type, Southeast Asia Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 73. India Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India Temporal Arteritis Market Share, 2022
Figure 75. By Type, India Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Temporal Arteritis Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Temporal Arteritis Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia Temporal Arteritis Market Share, 2022
Figure 79. By Type, Middle East & Asia Temporal Arteritis Sales Volume Market Share, 2022 VS 20
Research Methodology:
Temporal Arteritis Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|